Walgreens expands GLP-1 care and pharmacist support
New Walgreens services help eligible patients explore GLP-1 coverage and savings and connect with pharmacists after starting treatment.
GLP-1s
GLP-1 demand helps fuel compounding pharmacy market
Personalized medicine, GLP-1 supply gaps and demand for customized doses are helping drive growth in the compounding pharmacy market.
MasterClass launches GLP-1 education course
Endocrinologist Dr. Rocio Salas-Whalen leads a new MasterClass course designed to help patients better understand GLP-1 therapy.
North America leads rapidly growing GLP-1 market
The US drives growth via branded therapies, rising obesity, and broader use in diabetes and weight management.
PRI report warns of risks tied to unauthorized GLP-1 knockoffs
A new Pacific Research Institute report warns that unauthorized compounded GLP-1 drugs may pose patient safety risks and hinder future pharmaceutical innovation.
GLP-1 boom fuels whey protein shortage concerns
Record whey protein prices and tightening supplies highlight the ripple effects of growing GLP-1 adoption across the health and nutrition marketplace.
NACDS updates members on CMS Medicare GLP-1 Bridge Program rollout
NACDS is advising chain pharmacy members on the upcoming launch of the CMS Medicare GLP-1 Bridge Program, a temporary demonstration that will provide eligible Medicare beneficiaries with access to certain medications beginning July 1.
Employers wary of GLP-1 costs
Other new research, from Acosta Group, reveals that GLP-1s are reshaping consumer behavior including lifestyle, health and wellness, and personal care choices.
GLP-1 hydration market to reach $6 billion by 2036
Hydration products designed for GLP-1 medication users are a fast-growing category across wellness and pharmacy channels, driven by demand for low-sugar, digestive-friendly options.
Coffee Chat: Meg Rand, Acosta Group
GLP-1 users drive trends across range of product segments.
Harris Teeter expands GLP-1 access
Regional grocer integrates medications, dietitians and affordability tools to support weight management.
GLP-1 access expands with launch of oral Ozempic
Novo Nordisk is launching a pill form of Ozempic, offering a new option for type 2 diabetes and positioning pharmacies at the forefront of access, adherence, and the growing GLP-1 demand.
U.S. prescription drug spending on track to exceed $1 trillion
Weight-loss drugs drive historic growth in 2025.
GLP-1 ‘halo effect’ accelerates health-driven purchasing trends
New Acosta Group research shows GLP-1 users are driving shifts toward healthier eating, targeted wellness and new retail opportunities.
FDA approves Lilly’s Foundayo, first unrestricted GLP-1 pill
Oral GLP-1 therapy achieves double-digit weight loss in trials and launches this month with no food or water restrictions, expanding access through retail and direct-to-consumer channels.
Kroger pharmacies add Zepbound KwikPen
“Our customers and communities want affordable, effective weight-management treatment options with real affordability,” said Colleen Lindholz, group vice president and president of Kroger Health.